Possibia

6172777

Last Update Posted: 2024-09-05

Recruiting has ended

All Genders

accepted

18 Years +

72 Estimated Participants

No Expanded Access

Observational Study

Does not accept healthy volunteers

A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD

The study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD, it is a multi-centre clinical study. sponsor by Astrazeneca Investment(China) Co.,LTD.

800 patients, including suspected or confirmed asthma, suspected or confirmed COPD, will be enrolled in nationwide multiple study centres. Enrolling suspected and confirmed subject in an approximate1:1 rate in centre-level. About 100 subjects were enrolled at the leader site, while about 14 subjects were enrolled at other sites.

To evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD.

Eligibility

Relevant conditions:

Asthma/ COPD

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

AstraZeneca Clinical Study Information Center

information.center@astrazeneca.com

1-877-240-9479

Data sourced from ClinicalTrials.gov